NRC HEALTH (NRC) Form 8-K — Oct 27, 2026
NRC Health reported Q3 2026 revenue of $38.4 million, up 11% year-over-year, with GAAP net income of $4.7 million ($0.21 diluted EPS) and Adjusted EBITDA of $10.9 million (28% margin). Total Recurring Contract Value rose 9% YoY to $154.1 million, and CEO Trent Green highlighted that a large customer went live on schedule with several multi-year renewals signed. The Board declared a quarterly dividend of $0.16 per share payable January 8, 2027.
Key figures
- Eps
- 0.21
- Revenue
- 38399000
- Guidance
- No formal guidance; management cited expanding contract base converting to revenue, operating leverage, and greater profitability/free cash flow over time.
- Net Income
- 4704000
- Revenue Yoy
- 11%
- Total Assets
- 139213000
- Cash Position
- 3626000
- Shares Outstanding
- 21221538
- Trcv
- $154.1 million, up 9% YoY
- Ytd revenue
- $108.6 million
- Adjusted ebitda
- $10.9 million (28% of revenue)
- Free cash flow q3
- $7.0 million
- Dividend per share
- $0.16 quarterly, payable January 8, 2027
- Shareholders equity
- -$9.1 million (negative)
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.